EC approves Astellas’ PADCEV for urothelial cancer
The regimen is intended for adults with unresectable or metastatic urothelial cancer who are eligible for platinum-containing chemotherapy.
28 August 2024
28 August 2024
The regimen is intended for adults with unresectable or metastatic urothelial cancer who are eligible for platinum-containing chemotherapy.
The move significantly expands the supply of Zepbound in response to high demand and offers a more affordable option.
The situation is improving for GLP-1 receptor agonist supply, particularly for Lilly’s tirzepatide products, Zepbound and Mounjaro.
RA Capital Management partner Wouter Joustra and managing director Andrew Levin will join Navigator’s board of directors.
PfizerForAll consolidates critical resources and services, enabling individuals and families to take health actions.
Rybrevant has been granted a Type II approval extension to treat NSCLC with EGFR mutations following the failure of TKI therapy.
Unlike its close neighbour Thailand, Singapore has not yet confirmed an mpox clade Ib case.
Boosting transparency, deploying automation, increasing efficiency – supply chain chiefs are balancing these and many other objectives simultaneously. All are founded on the benefits offered by supply chain digitalisation.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.